Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's Disease

in 't Veld, Bas A., Ruitenberg, Annemieke, Hofman, Albert, Launer, Lenore J., van Duijn, Cornelia M., Stijnen, Theo, Breteler, Monique M.B., Stricker, Bruno H.C.·2001·New England Journal of Medicine

DOI 10.1056/nejmoa010178

Cited by (1,000)

Items 601–700 of 1,000

Can krill oil be of use for counteracting neuroinflammatory processes induced by high fat diet and aging?
John M. Andraka, Naveen Sharma, Yannick Marchalant · 2019 · Neuroscience Research
Adult Hippocampal Neurogenesis in Alzheimer's Disease: An Overview of Human and Animal Studies with Implications for Therapeutic Perspectives Aimed at Memory Recovery
S. Farioli-Vecchioli, Valentina Ricci, S. Middei · 2022 · Journal of Neural Transplantation and Plasticity
The Mitochondrial Secret(ase) of Alzheimer's Disease
Kisha J. Young, James P. Bennett · 2010 · Journal of Alzheimer s Disease
Inhibition of Amyloidogenesis by Nonsteroidal Anti-inflammatory Drugs and Their Hybrid Nitrates
Isaac T. Schiefer, Samer O. Abdul‐Hay, Huali Wang, Michael Vanni, Zhihui Qin, Gregory R. J. Thatcher · 2011 · Journal of Medicinal Chemistry
Levuglandins and Isolevuglandins: Stealthy Toxins of Oxidative Injury
Robert G. Salomon · 2004 · Antioxidants and Redox Signaling
Neural stem cells in inflammatory CNS diseases: mechanisms and therapy
Tim Magnus, M.S. Rama Rao · 2005 · Journal of Cellular and Molecular Medicine
Kinins and neuroinflammation: Dual effect on prostaglandin synthesis
Avital Levant, Einat Levy, Miriam Argaman · 2006 · European Journal of Pharmacology
Nonsteroidal Anti-inflammatory Drugs Protect Against Parkinson Neurodegeneration
Mya Caryn Schiess · 2003 · Archives of Neurology
Editorial: Danger Signals Triggering Immune Response and Inflammation
Abdulraouf M. Ramadan, Walter Gottlieb Land, Sophie Paczesny · 2017 · Frontiers in Immunology
Alzheimer’s disease: From basic science to precision medicine approach
Forloni, Gianluigi · 2020 · BMJ Neurology Open
Molecular Mechanism for Various Pharmacological Activities of NSAIDS
Tohru Mizushima · 2010 · Pharmaceuticals
A Population Study of Alzheimer's Disease: Findings From the Cache County Study on Memory, Health, and Aging
JoAnn T. Tschanz, Katherine Treiber, Maria C. Norton, Kathleen Anne Welsh-Bohmer, Leslie Toone, Peter P. Zandi, Christine A. Szekely, Constantine George Lyketsos, John C.S. Breitner, The Cache County Study Group · 2005 · Care management journals
Drug discovery and development focusing on existing medicines: drug re-profiling strategy
T. Mizushima · 2011 · The Journal of Biochemistry
Epidemiology of neurological diseases in elderly people: what did we learn from the Rotterdam Study?
Albert Hofman D, Paulus T.V.M. de Jong, Cornelia M. van Duijn, Monique M.B. Breteler · 2006 · The Lancet Neurology
DP‐155, a Lecithin Derivative of Indomethacin, is a Novel Nonsteroidal Antiinflammatory Drug for Analgesia and Alzheimer's Disease Therapy
Eran Dvir, Anat Elman, Danielle A. Simmons, Israel Shapiro, Revital Duvdevani, Arik Dahan, Amnon Hoffman, Jonathan E. Friedman · 2007 · CNS Drug Reviews
Frontiers in Alzheimer’s disease therapeutics
Jeremy G. Stone, Gemma Casadesús, Kasia Gustaw Rothenberg, Sandra L. Siedlak, Xinglong Wang, Xiongwei Zhu, George L. Perry, Rudy J. Castellani, Mark A. Smith · 2010 · Therapeutic Advances in Chronic Disease
miRNA 933 Expression by Endothelial Cells is Increased by 27-Hydroxycholesterol and is More Prevalent in Plasma from Dementia Patients
Irundika H.K. Dias, Caroline L. Brown, Kiran Shabir, Maria Cristina Polidori, Helen R. Griffiths · 2018 · Journal of Alzheimer s Disease
Gut Inflammation Induced by Dextran Sulfate Sodium Exacerbates Amyloid-β Plaque Deposition in the App NL – G – F Mouse Model of Alzheimer’s Disease
Mona Sohrabi, Heidi L. Pecoraro, Colin Kelly Combs · 2021 · Journal of Alzheimer s Disease
Long-term aspirin pretreatment in the prevention of cerulein-induced acute pancreatitis in rats
İbrahim Akyazı, Evren Eraslan, Ahmet Gülçubuk, Elif Ergül Ekiz, Zeynep Cirakli, Damla Haktanır, Deniz Aktaran Bala, Mete Özkurt, Erdal Matur, Mukaddes Özcan · 2013 · World Journal of Gastroenterology
Molecular basis for anti-amyloid therapy in the prevention and treatment of Alzheimer’s disease
Sam Gandy · 2002 · Neurobiology of Aging
Pharmacokinetics of Cromolyn and Ibuprofen in Healthy Elderly Volunteers
Brazier, David, Perry, Robert, Keane, Jim, Barrett, Katie, Elmaleh, David R. · 2017 · Clinical Drug Investigation
Inflammation in the Alzheimer's disease cascade: culprit or innocent bystander?
Tan, Zaldy S, Seshadri, Sudha · 2010 · Alzheimer's Research & Therapy
Structural Mechanism of the Interaction of Alzheimer Disease Aβ Fibrils with the Non-steroidal Anti-inflammatory Drug (NSAID) Sulindac Sulfide
Elke Prade, Heiko J. Bittner, Riddhiman Sarkar, Juan Miguel López del Amo, Gerhard Althoff-Ospelt, Gerd Multhaup, Peter Werner Hildebrand, Bernd Reif · 2015 · Journal of Biological Chemistry
Isoorientin Affects Markers of Alzheimer's Disease via Effects on the Oral and Gut Microbiota in APP/PS1 Mice
Zhongbao Zhang, Xiaoqin Tan, Xiaorong Sun, Jianhua Wei, Qing X. Li, Zhongyi Wu · 2021 · Journal of Nutrition
Cognitive Enhancers (Nootropics). Part 2: Drugs Interacting with Enzymes
Wolfgang Froestl, Andreas Muhs, Andrea Pfeifer · 2013 · Journal of Alzheimer s Disease
Estimating and disclosing the risk of developing Alzheimer‘s disease: challenges, controversies and future directions
Jeffrey Scott Roberts, Sarah M Tersegno · 2010 · Future Neurology
Involvement of interleukin‐1 in lipopolysaccaride‐induced microglial activation and learning and memory deficits
Sachiko Tanaka, H. Kondo, K. Kanda, Takashi Ashino, Tomoya Nakamachi, Kenji Sekikawa, Yoichiro Iwakura, Seiji Shioda, Satoshi Numazawa, Tetsuya Yoshida · 2011 · Journal of Neuroscience Research
Chronic disease long‐term drug prevention trials: Lessons from the Alzheimer's Disease Anti‐inflammatory Prevention Trial (ADAPT)
Curtis L. Meinert, John C.S. Breitner · 2007 · Alzheimer s & Dementia
INFLAMMATION AND ALZHEIMER'S DISEASE
Akhil Gupta, Kalpana Pansari · 2003 · International Journal of Clinical Practice
Stearoylethanolamide interferes with retrograde endocannabinoid signalling and supports the blood-brain barrier integrity under acute systemic inflammation
L.A. Kasatkina, Ákos Heinemann, Yehor A. Hudz, Dominique Thomas, Eva Maria Sturm · 2019 · Biochemical Pharmacology
The Association Between Osteoarthritis with Risk of Dementia and Cognitive Impairment: A Meta-Analysis and Systematic Review
Rong Guo, Ya‐Nan Ou, He‐Ying Hu, Ya‐Hui Ma, Lan Tan, Jin‐Tai Yu · 2022 · Journal of Alzheimer s Disease
Microsomal prostaglandin E synthase-2: Cellular distribution and expression in Alzheimer's disease
Uzma A. Chaudhry, Hean Zhuang, Sylvain Doré · 2009 · Experimental Neurology
p38 Mitogen Activated Protein Kinase as a Therapeutic Target for Alzheimer's Disease
Stacie A. Dalrymple · 2002 · Journal of Molecular Neuroscience
Curcumin Requires Tumor Necrosis Factor α Signaling to Alleviate Cognitive Impairment Elicited by Lipopolysaccharide
Elisa Mitiko Kawamoto, Cristóforo Scavone, Mark P. Mattson, Simonetta Camandola · 2012 · Neurosignals
Quetiapine Attenuates Glial Activation and Proinflammatory Cytokines in APP/PS1 Transgenic Mice via Inhibition of Nuclear Factor- B Pathway
S. Zhu, R. Shi, Victor Li, Jiuju Wang, Rui Zhang, Adrien Tempier, J. He, Jiming Kong, Junfeng Wang, X.-M. Li · 2014 · The International Journal of Neuropsychopharmacology
A nitric oxide-donating flurbiprofen derivative reduces neuroinflammation without interacting with galantamine in the rat
Gary L. Wenk, Susanna Rosi, Kristin McGann, Beatrice Hauss‐Wegrzyniak · 2002 · European Journal of Pharmacology
Histamine Induces Alzheimer’s Disease-Like Blood Brain Barrier Breach and Local Cellular Responses in Mouse Brain Organotypic Cultures
Jonathan C. Sedeyn, Hao Wu, Reilly D. Hobbs, Eli C. Levin, Robert G. Nagele, Venkat Venkataraman · 2015 · BioMed Research International
Evolution by Phenotype: A Biomedical Perspective
Kenneth M. Weiss, Anne V. Buchanan · 2003 · Perspectives in biology and medicine
Flurbiprofen sodium microparticles and soft pellets for nose-to-brain delivery: Serum and brain levels in rats after nasal insufflation
Laura Tiozzo Fasiolo, Michele Dario Manniello, Sabrina Banella, Laura Napoli, Fabrizio Bortolotti, Eride Quarta, Paolo Colombo, Evangelos Balafas, Nikolaos G Kostomitsopoulos, Dimitrios M. Rekkas et al. · 2021 · International Journal of Pharmaceutics
The role of IL-15 in central nervous system disorders
Michael Rentzos, A. Rombos · 2011 · Acta Neurologica Scandinavica
Fluorinated piperidine acetic acids as γ-secretase modulators
Matthew G. Stanton, Jed L. Hubbs, David L. Sloman, Christopher L. Hamblett, Paula B. Andrade, Minilik H. Angagaw, Grace Bi, Regina M. Black, Jamie L. Crispino, Jonathan C. Cruz et al. · 2009 · Bioorganic & Medicinal Chemistry Letters
Cyclooxygenase-Dependent Lipid-Modification of Brain Proteins
Olivier G. Boutaud, Katrin I. Andreasson, Irene A. Zagol-Ikapitte, John A. Oates · 2006 · Brain Pathology
Pyridine-derived γ-secretase modulators
Zehong Wan, Adrian Hall, Yingxia Sang, Jia‐Ning Xiang, Eric Yang, Beverley B. Smith, David C. Harrison, Guang Zhong Yang, Haihua Yu, Helen S. Price et al. · 2011 · Bioorganic & Medicinal Chemistry Letters
Solid-phase molecularly imprinted pre-concentration and spectrophotometric determination of isoxicam in pharmaceuticals and human serum
Behzad Rezaei, Shadpour E Mallakpour, Najmeh Majidi · 2008 · Talanta
Exposure‐time‐varying hazard function ratios in case‐control studies of drug effects
Harry A. Guess · 2005 · Pharmacoepidemiology and Drug Safety
Developing new treatments for Alzheimer's disease: the who, what, when, and how of biomarker-guided therapies
Constantine George Lyketsos, Christine A. Szekely, Michelle M. Mielke, Paul B. Rosenberg, Peter P. Zandi · 2008 · International Psychogeriatrics
Alzheimer's Disease:Progress in the Development of Anti-amyloid Disease-Modifying Therapies
Daniel D. Christensen · 2007 · CNS Spectrums
The Clock-Drawing Test in Elderly Italian Community Dwellers: Associations with Sociodemographic Status and Risk Factors for Vascular Cognitive Impairment
Giovanni Ravaglia, Paola Forti, F. Maioli, Giorgia Arnone, Gaia Pantieri, Cinzia Cocci, Valeria Nativio, Antonio Muscari, Vincenzo Pedone, Erminia Mariani · 2003 · Dementia and Geriatric Cognitive Disorders
Presenilin/γ-secretase and inflammation
Carlos A. Saura · 2010 · Frontiers in Aging Neuroscience
Is there a Future for Cyclo-Oxygenase Inhibitors in Alzheimer???s Disease?
Lap Ho, Weiping Qin, Breton Stetka, Giulio Maria Pasinetti · 2006 · CNS Drugs
Inhibition of cyclooxygenase as potential novel therapeutic strategy in N141I presenilin-2 familial Alzheimer's disease
Weiping Qin, Y Peng, Hanna Ksiȩżak-Reding, Lap Ho, Breton Stetka, Eleonora Lovati, Giulio Maria Pasinetti · 2005 · Molecular Psychiatry
A Novel Phospholipid Derivative of Indomethacin, DP-155 [Mixture of 1-Steroyl and 1-Palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido]hexanoyl}-sn-glycero-3-phosophatidyl Choline], Shows Superior Safety and Similar Efficacy in Reducing Brain Amyloid β in an Alzheimer’s Disease Model
Eran Dvir, Jonathan E. Friedman, Jun Young Lee, Jae‐Young Koh, Firas M. Younis, Shmuel Raz, I. Shapiro, Amnon Hoffman, Arik Dahan, Gilad Rosenberg et al. · 2006 · Journal of Pharmacology and Experimental Therapeutics
Multi-Target Neuroprotection of Thiazolidinediones on Alzheimer’s Disease via Neuroinflammation and Ferroptosis
Jiahui Yang, Xiaohua Shi, Yingying Wang, Ming Ma, Hongyu Liu, Jiaoqi Wang, Zhongxin Xu · 2023 · Journal of Alzheimer s Disease
Histamine‐2 Receptor Antagonist Use and Incident Dementia in an Older Cohort
Shelly L. Gray, Rod L. Walker, Sascha Dublin, Sebastien Haneuse, Paul K. Crane, John C.S. Breitner, James Bowen, Wayne C. McCormick, Eric Berg Larson · 2011 · Journal of the American Geriatrics Society
Identification and modification of amyloid-independent phenotypes of APOE4 mice
Amanda Marie DiBattista, Sonya B. Dumanis, Joshua Newman, George William Rebeck · 2016 · Experimental Neurology
Overcoming translational barriers impeding development of Alzheimer's disease modifying therapies
Todd Eliot Golde · 2016 · Journal of Neurochemistry
Novel celecoxib analogues inhibit glial production of prostaglandin E2, nitric oxide, and oxygen radicals reverting the neuroinflammatory responses induced by misfolded prion protein fragment 90-231 or lipopolysaccharide
Valentina Villa, Stefano Thellung, Adriana Bajetto, Elena Gatta, Mauro Robello, Federica Novelli, Bruno Tasso, Michele Tonelli, Tullio Florio · 2016 · Pharmacological Research
A dual inhibitor of the proteasome catalytic subunits LMP2 and Y attenuates disease progression in mouse models of Alzheimer’s disease
In Jun Yeo, Min Jae Lee, Ahruem Baek, Zachary C. Miller, Deepak Bhattarai, Yu Mi Baek, Hyun Jung Jeong, Yun Kyung Kim, Dong‐Eun Kim, Jin Tae Hong et al. · 2019 · Scientific Reports
Antiinflammatory and Analgesic Activities of Ethanol Extract and Isolated Compounds from Millettia pulchra
Xiaowei Huo, Leilei Zhang, Li Gao, Yan Guo, Lijing Zhang, Liyong Li, Jianyong Si, Li Cao · 2015 · Biological and Pharmaceutical Bulletin
Therapeutic Perspectives in Alzheimers Disease
Jakob‐A. Tschäpe, Tobias Hartmann · 2006 · Recent Patents on CNS Drug Discovery
Inflammatory Cyclooxygenase Activity and PGE2 Signaling in Models of Alzheimer’s Disease
Jenny U. Johansson, Nathaniel S. Woodling, Ju Shi, Katrin I. Andreasson · 2015 · Current Immunology Reviews
Lost in Translation
Mary Ganguli, Walter A. Kukull · 2010 · Archives of Neurology
Clinically tested drugs for Alzheimer?s disease
Edith G. McGeer, Patrick L. McGeer · 2003 · Expert Opinion on Investigational Drugs
Lessons from Microglia Aging for the Link between Inflammatory Bone Disorders and Alzheimer’s Disease
Zhou Wu, Hiroshi Nakanishi · 2015 · Journal of Immunology Research
Asiaticoside Mitigates Alzheimer’s Disease Pathology by Attenuating Inflammation and Enhancing Synaptic Function
Sai Liu, Long Chen, Jinran Li, Yuan Sun, Yue Xu, Zhaoxing Li, Zheying Zhu, Xinuo Li · 2023 · International Journal of Molecular Sciences
Pathways towards an effective immunotherapy for Parkinson’s disease
Jessica A.L. Hutter-Saunders, Rodney Lee Mosley, Howard Eliot Gendelman · 2011 · Expert Review of Neurotherapeutics
Quinones bearing non-steroidal anti-inflammatory fragments as multitarget ligands for Alzheimer’s disease
Federica Prati, Manuela Bartolini, Elena Simoni, Angela De Simone, Antonella Pinto, Vincenza Andrisano, María Laura Bolognesi · 2013 · Bioorganic & Medicinal Chemistry Letters
Anti-inflammatory drugs reduce age-related decreases in brain volume in cognitively normal older adults
Katrin Walther, Barbara B. Bendlin, Elizabeth Louise Glisky, Theodore P. Trouard, JEFFREY R. LISSE, James O. Posever, Lee Ryan · 2009 · Neurobiology of Aging
Prevention strategies for Alzheimer’s disease
Serge G. Gauthier, Liyong Wu, Pedro Rosa‐Neto, Jianping Jia · 2012 · Translational Neurodegeneration
Processing of Amyloid Precursor Protein as a Biochemical Link Between Atherosclerosis and Alzheimers Disease
David A. Jans, Wim Martinet, Tim J.L. van de Parre, A.G. Herman, Hidde Bult, Mark M. Kockx, Guido R.Y. De Meyer · 2006 · Cardiovascular & Haematological Disorders - Drug Targets
Elevation of serum TNF-α levels in mild and moderate Alzheimer patients with daytime sleepiness
Rui Chen, You Yin, Zhongxin Zhao, Liuqing Huang, Shuqi Huang, Jianhua Zhuang, Huijuan Wu, Hua Peng, Peng Li · 2012 · Journal of Neuroimmunology
Effect of non‐steroidal anti‐inflammatory medications on the risk of amyotrophic lateral sclerosis
Rita A. Popat, Caroline M. Tanner, Stephen K. Van Den Eeden, ALLAN L. BERNSTEIN, D A Bloch, Amethyst D. Leimpeter, Valerie M. McGuire, Lorene M. Nelson · 2007 · Amyotrophic Lateral Sclerosis
Identification of sodium salicylate as an hsp inducer using a simple screening system for stress response modulators in mammalian cells
Keiichi Ishihara, Kenji Horiguchi, Nobuyuki Yamagishi, Takumi Hatayama · 2003 · European Journal of Biochemistry
Pharmacotherapy for Alzheimer's Disease: 2002
David S. Knopman · 2003 · Clinical Neuropharmacology
NSAIDs and Alzheimer's disease: how far to generalise from trials?
John C.S. Breitner · 2003 · The Lancet Neurology
Facts and Ideas from Anywhere
William Clifford Roberts · 2004 · Baylor University Medical Center Proceedings
Once-daily transdermal rivastigmine in the treatment of Alzheimer’s disease
Richard C. Dodel · 2008 · Drug Design Development and Therapy
Prévalence, incidence et facteurs de risque de la maladie d'Alzheimer
Joël Ankri · 2009 · Gérontologie et société
Inhibition of Double-Stranded RNA-Dependent Protein Kinase Strongly Decreases Cytokine Production and Release in Peripheral Blood Mononuclear Cells from Patients with Alzheimer's Disease
Julien Couturier, Guylène Page, Miléna Morel, C Gontier, Jean‐Claude Lecron, Raymond Pontcharraud, Bernard Fauconneau, Marc Paccalin · 2010 · Journal of Alzheimer s Disease
NSAID Use and Incident Cognitive Impairment in a Population-based Cohort
Margarete A. Wichmann, Karen J. Cruickshanks, Cynthia M. Carlsson, Rick J Chappell, Mary Fischer, Ronald Klein, Ronald Klein, Carla R. Schubert · 2015 · Alzheimer Disease & Associated Disorders
Antioxidants and Dementia Risk: Consideration through a Cerebrovascular Perspective
Virginie Lam, Mark J. Hackett, Ryusuke Takechi · 2016 · Nutrients
Effects of medications on plasma amyloid beta (Aβ) 42: Longitudinal data from the VITA cohort
Imrich Blasko, Susanne Jungwirth, K. A. Jellinger, Georg Kemmler, Wolfgang W. Krampla, Silvia Weissgram, Ildiko Wichart, Karl Heinz Tragl, Hartmann Hinterhuber, Peter A. Fischer · 2007 · Journal of Psychiatric Research
Blockade of chloride intracellular ion channel 1 stimulates Aβ phagocytosis
Silvia Paradisi, Andrea Matteucci, Cinzia Fabrizi, Michela A. Denti, Rosella Abeti, Samuel N. Breit, Fiorella Malchiodi‐Albedi, Michele Mazzanti · 2008 · Journal of Neuroscience Research
A novel compound, RS-1178, specifically inhibits neuronal cell death mediated by β-amyloid-induced macrophage activation in vitro
Shigeko Uryu, Shinya Tokuhiro, Takako Murasugi, Tomiichiro Oda · 2002 · Brain Research
Inflammatory processes and Alzheimer’s disease
Sally P. Walsh, Paul S. S. Aisen · 2004 · Expert Review of Neurotherapeutics
Replication of the association of HLA-B7 with Alzheimer's disease: a role for homozygosity?
Donald J. Lehmann, Martin Barnardo, Susan V. Fuggle · 2006 · Journal of Neuroinflammation
Alzheimer vaccine: amyloid‐β on trial
Stephen R. Robinson, Glenda M. Bishop, Gerald W Münch · 2003 · BioEssays
Molecular drug targets and therapies for Alzheimer’s disease
Dev Bukhsh Singh, Manish Gupta, Rajesh Kumar Kesharwani, Mamta Sagar, Seema Dwivedi, Krishna Misra · 2014 · Translational Neuroscience
Inflammation in Alzheimer’s disease
Michael Thomas Heneka · 2006 · Clinical Neuroscience Research
Will testing for apolipoprotein E assist in tailoring dementia risk reduction? A review
Lee‐Fay Low, Melvyn Yap, Henry Brodaty · 2009 · Neuroscience & Biobehavioral Reviews
Effect of the PGD2-DP signaling pathway on primary cultured rat hippocampal neuron injury caused by aluminum overload
Jie Ma, Qunfang Yang, Yuling Wei et al. · 2016 · Scientific Reports
Protein and Peptides for Elderly Health
Nan Shang, Meram Chalamaiah, Nandika Bandara, Jianping Wu · 2018 · Advances in protein chemistry and structural biology
Celecoxib Inhibits Prion Protein 90-231-Mediated Pro-inflammatory Responses in Microglial Cells
Valentina Villa, Stefano Thellung, Alessandro Corsaro, Federica Novelli, Bruno Tasso, Luca Colucci-D’Amato, Elena Gatta, Michele Tonelli, Tullio Florio · 2014 · Molecular Neurobiology
What have we learned from past failures of investigational drugs for Alzheimer’s disease?
Bruno Pietro Imbimbo, Mark I L Watling · 2021 · Expert Opinion on Investigational Drugs
Patterns of anti‐inflammatory drug use and risk of dementia: a matched case–control study
Alex Dregan, Phil Chowienczyk, David Armstrong · 2015 · European Journal of Neurology
Clearance of Amyloid Beta Plaques from Brain of Alzheimeric Rats by Lavandula angustifolia
Masoud Soheili, Mostafa Rezaei–Tavirani, Mahmoud Salami · 2012 · Neuroscience & Medicine
S- but not R-enantiomers of flurbiprofen and ibuprofen reduce human microglial and THP-1 cell neurotoxicity
Andis Klegeris, John A. Maguire, Patrick L. McGeer · 2004 · Journal of Neuroimmunology
Stem cell transplantation improves aging-related diseases
Susumu Ikehara, Ming Li · 2014 · Frontiers in Cell and Developmental Biology
N-Substituted carbazolyloxyacetic acids modulate Alzheimer associated γ-secretase
Rajeshwar Narlawar, Blanca Isabel Pérez‐Revuelta, Karlheinz Baumann, Robert Schubenel, Christian Haass, Harald Steiner, Boris Schmidt · 2006 · Bioorganic & Medicinal Chemistry Letters
N-3 polyunsaturated fatty acid and neuroinflammation in aging and Alzheimer's disease
Sophie Layé, Charlotte Madore, Isabelle St‐Amour, Jean-Christophe Delpech, Corinne Joffre, Agnès Nadjar, Frédéric Calon · 2015 · Nutrition and Aging